| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4004598 | American Journal of Ophthalmology | 2007 | 11 Pages |
Abstract
The loss of the downregulatory immune environment is central to the development of AMD, permitting activation of the immune system. If so, immunotherapy could positively alter the course of the disease.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Robert B. Nussenblatt, Frederick III,